Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients
NCT01539915
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
BCT194
Sponsor
Novartis Pharmaceuticals